Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
19.75
+0.46 (2.38%)
At close: Mar 6, 2026, 4:00 PM EST
19.88
+0.13 (0.66%)
After-hours: Mar 6, 2026, 7:00 PM EST
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Pediatrix Medical Group stock have an average target of 20, with a low estimate of 17 and a high estimate of 22. The average target predicts an increase of 1.27% from the current stock price of 19.75.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $23 → $22 | Hold | Maintains | $23 → $22 | +11.39% | Feb 24, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $24 → $21 | Hold | Maintains | $24 → $21 | +6.33% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | +21.52% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $17 → $23 | Hold | Maintains | $17 → $23 | +16.46% | Nov 5, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | -13.92% | Sep 5, 2025 |
Financial Forecast
Revenue This Year
1.99B
from 1.91B
Increased by 3.72%
Revenue Next Year
2.04B
from 1.99B
Increased by 2.62%
EPS This Year
2.30
from 1.94
Increased by 18.62%
EPS Next Year
2.40
from 2.30
Increased by 4.18%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.0B | 2.1B | ||
| Avg | 2.0B | 2.0B | ||
| Low | 1.9B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.7% | 7.1% | ||
| Avg | 3.7% | 2.6% | ||
| Low | -2.0% | -4.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.48 | 2.70 | ||
| Avg | 2.30 | 2.40 | ||
| Low | 2.12 | 2.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 27.7% | 17.3% | ||
| Avg | 18.6% | 4.2% | ||
| Low | 9.1% | -9.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.